{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:19:55Z","timestamp":1790039995790,"version":"4.0.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2005,9,15]],"date-time":"2005-09-15T00:00:00Z","timestamp":1126742400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,9,15]],"date-time":"2005-09-15T00:00:00Z","timestamp":1126742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1038\/sj.leu.2403920","type":"journal-article","created":{"date-parts":[[2005,11,22]],"date-time":"2005-11-22T17:01:56Z","timestamp":1132678916000},"page":"2030-2042","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":186,"title":["Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials"],"prefix":"10.1038","volume":"19","author":[{"given":"U","family":"Creutzig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Reinhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Henze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"J\u00fcrgens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Kabisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Reiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Riehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Gadner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Schellong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the AML-BFM Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,9,15]]},"reference":[{"key":"BF2403920_CR1","first-page":"89","volume":"189","author":"H Riehm","year":"1977","unstructured":"Riehm H, Gadner H, Welte K . Die West-Berliner Studie zur Behandlung der akuten lymphoblastischen Leuk\u00e4mie des Kindes \u2013 Erfahrungsbericht nach 6 Jahren. Klin P\u00e4diatr 1977; 189: 89\u2013102.","journal-title":"Klin P\u00e4diatr"},{"key":"BF2403920_CR2","first-page":"210","volume":"191","author":"U Scheer","year":"1979","unstructured":"Scheer U, Schellong G, Riehm H . Verbesserte Prognose der akuten myeloischen Leuk\u00e4mien bei Kindern nach intensivierter Anfangstherapie. Klin P\u00e4diatr 1979; 191: 210\u2013216.","journal-title":"Klin P\u00e4diatr"},{"key":"BF2403920_CR3","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1182\/blood.V65.2.298.298","volume":"65","author":"U Creutzig","year":"1985","unstructured":"Creutzig U, Ritter J, Riehm H, Langermann H-J, Henze G, Kabisch H et al. Improved treatment results in childhood acute myelogenous leukemia: a report of the German cooperative study AML-BFM-78. Blood 1985; 65: 298\u2013304.","journal-title":"Blood"},{"key":"BF2403920_CR4","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1182\/blood.V58.6.1203.1203","volume":"58","author":"KR Rai","year":"1981","unstructured":"Rai KR, Holland JF, Glidewell OJ, Weinberg V, Brunner K, Obrecht JP et al. Treatment of acute myelocytic leukemia: a study by Cancer and Leukemia Group B. Blood 1981; 58: 1203\u20131212.","journal-title":"Blood"},{"key":"BF2403920_CR5","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1200\/JCO.1985.3.12.1583","volume":"3","author":"T B\u00fcchner","year":"1985","unstructured":"B\u00fcchner T, Urbanitz D, Hiddemann W, R\u00fchl H, Ludwig WD, Fischer J et al. Intensified induction and consolidation with or without maintenance chemotherapy for acute myeloid leukemia (AML): two multicenter studies of the German AML Cooperative Group. J Clin Oncol 1985; 3: 1583\u20131589.","journal-title":"J Clin Oncol"},{"key":"BF2403920_CR6","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1182\/blood.V75.10.1932.1932","volume":"75","author":"U Creutzig","year":"1990","unstructured":"Creutzig U, Ritter J, Schellong G . Identification of two risk groups in childhood acute myelogenous leukemia after therapy intensification in the study AML-BFM-83 as compared with study AML-BFM-78. Blood 1990; 75: 1932\u20131940.","journal-title":"Blood"},{"key":"BF2403920_CR7","first-page":"1269","volume":"68","author":"RL Baehner","year":"1984","unstructured":"Baehner RL, Bernstein ID, Sather H, Higgins G, McCreadie S, Chard RL et al. Contrasting benefits of two maintenance programs following identical induction in children with acute nonlymphocytic leukemia: a report from the Childrens Cancer Study Group. Cancer Treat Rep 1984; 68: 1269\u20131272.","journal-title":"Cancer Treat Rep"},{"key":"BF2403920_CR8","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1542\/peds.50.2.246","volume":"50","author":"D Pinkel","year":"1972","unstructured":"Pinkel D, Simone J, Hustu HO, Aur RJ . Nine years' experience with \u2018total therapy\u2019 of childhood acute lymphocytic leukemia. Pediatrics 1972; 50: 246\u2013251.","journal-title":"Pediatrics"},{"key":"BF2403920_CR9","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1002\/1097-0142(197811)42:5<2187::AID-CNCR2820420516>3.0.CO;2-Q","volume":"42","author":"GV Dahl","year":"1978","unstructured":"Dahl GV, Simone JV, Hustu HO, Mason C . Preventive central nervous system irradiation in children with acute nonlymphocytic leukemia. Cancer 1978; 42: 2187\u20132192.","journal-title":"Cancer"},{"key":"BF2403920_CR10","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1055\/s-2008-1033708","volume":"200","author":"U Creutzig","year":"1988","unstructured":"Creutzig U, Hofmann J, Ritter J, Schellong G . Therapierealisierung und Komplikationen in der Therapiestudie BFM-83 f\u00fcr die akute myeloische Leuk\u00e4mie. Klin P\u00e4diatr 1988; 200: 190\u2013199.","journal-title":"Klin P\u00e4diatr"},{"key":"BF2403920_CR11","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1046\/j.1365-2141.1999.01304.x","volume":"104","author":"U Creutzig","year":"1999","unstructured":"Creutzig U, Zimmermann M, Ritter J, Henze G, Graf N, L\u00f6ffler H et al. Definition of a standard-risk group in children with AML. Br J Haematol 1999; 104: 630\u2013639.","journal-title":"Br J Haematol"},{"key":"BF2403920_CR12","first-page":"159","volume":"75","author":"AM Carella","year":"1990","unstructured":"Carella AM, Berman E, Maraone MP, Ganzina F . Idarubicin in the treatment of acute leukemias. An overview of preclinical and clinical studies. Haematologica 1990; 75: 159\u2013169.","journal-title":"Haematologica"},{"key":"BF2403920_CR13","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1182\/blood.V79.12.3267.3267","volume":"79","author":"E Berman","year":"1992","unstructured":"Berman E, McBride M . Comparative cellular pharmacology of daunorubicin and idarubicin in human multidrug-resistant leukemia cells. Blood 1992; 79: 3267\u20133273.","journal-title":"Blood"},{"key":"BF2403920_CR14","doi-asserted-by":"publisher","first-page":"690","DOI":"10.2165\/00003495-199142040-00010","volume":"42","author":"LM Hollingshead","year":"1991","unstructured":"Hollingshead LM, Faulds D . Idarubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer. Drugs 1991; 42: 690\u2013719.","journal-title":"Drugs"},{"key":"BF2403920_CR15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.7326\/0003-4819-125-1-199607010-00008","volume":"125","author":"S Kesavan","year":"1996","unstructured":"Kesavan S, Lincoff AM, Young JB . Anthracycline-induced cardiotoxicity. Ann Intern Med 1996; 125: 47\u201358.","journal-title":"Ann Intern Med"},{"key":"BF2403920_CR16","first-page":"4116","volume":"93","author":"T B\u00fcchner","year":"1999","unstructured":"B\u00fcchner T, Hiddemann W, W\u00f6rmann B, L\u00f6ffler H, Gassmann W, Haferlach T et al. Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: a randomized trial by the German AML Cooperative Group. Blood 1999; 93: 4116\u20134124.","journal-title":"Blood"},{"key":"BF2403920_CR17","doi-asserted-by":"publisher","first-page":"626","DOI":"10.7326\/0003-4819-103-4-626","volume":"103","author":"JM Bennett","year":"1985","unstructured":"Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR et al. Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med 1985; 103: 626\u2013629.","journal-title":"Ann Intern Med"},{"key":"BF2403920_CR18","doi-asserted-by":"publisher","first-page":"460","DOI":"10.7326\/0003-4819-103-3-460","volume":"103","author":"JM Bennett","year":"1985","unstructured":"Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR et al. Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French\u2013American\u2013British Cooperative Group. Ann Intern Med 1985; 103: 460\u2013462.","journal-title":"Ann Intern Med"},{"key":"BF2403920_CR19","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1365-2141.1991.tb04444.x","volume":"78","author":"JM Bennett","year":"1991","unstructured":"Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR et al. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-M0). Br J Haematol 1991; 78: 325\u2013329.","journal-title":"Br J Haematol"},{"key":"BF2403920_CR20","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1200\/JCO.1990.8.5.813","volume":"8","author":"BD Cheson","year":"1990","unstructured":"Cheson BD, Cassileth PA, Head DR, Schiffer CA, Bennett JM, Bloomfield CD et al. Report of the National Cancer Institute-sponsored workshop on definitions and response in acute myeloid leukemia. J Clin Oncol 1990; 8: 813\u2013819.","journal-title":"J Clin Oncol"},{"key":"BF2403920_CR21","unstructured":"The National Cancer Institute. Investigators Handbook, A Manual for Participants in Clinical Trials of Investigational Agents Sponsored by the Division of Cancer Treatment. The National Cancer Institute, Washington, 1986."},{"key":"BF2403920_CR22","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/sj.leu.2402046","volume":"15","author":"U Creutzig","year":"2001","unstructured":"Creutzig U, Ritter J, Zimmermann M, Hermann J, Gadner H, Bl\u00fctters-Sawatzki R, et al, for the AML-BFM Study Group. Idarubicin improves blast cell clearance during induction therapy in children with AML: results of study AML-BFM 93. Leukemia 2001; 15: 348\u2013354.","journal-title":"Leukemia"},{"key":"BF2403920_CR23","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1055\/s-2001-16849","volume":"213","author":"U Creutzig","year":"2001","unstructured":"Creutzig U, Berthold F, Boos J, Fleischhack G, Gadner H, Gnekow A et al. Improved treatment results in children with AML: results of study AML-BFM 93]. Klin P\u00e4diatr 2001; 213: 175\u2013185.","journal-title":"Klin P\u00e4diatr"},{"key":"BF2403920_CR24","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1200\/JCO.2001.19.10.2705","volume":"19","author":"U Creutzig","year":"2001","unstructured":"Creutzig U, Ritter J, Zimmermann M, Reinhardt D, Hermann J, Berthold F, et al, for the AML-BFM Study Group. Improved treatment results in high risk pediatric AML patients after intensification with high dose Ara-C and mitoxantrone: results of study AML-BFM 93. J Clin Oncol 2001; 19: 2705\u20132713.","journal-title":"J Clin Oncol"},{"key":"BF2403920_CR25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1055\/s-2002-19861","volume":"214","author":"D Reinhardt","year":"2002","unstructured":"Reinhardt D, Thiele C, Creutzig U . Neuropsychological sequelae in children with AML treated with or without prophylactic CNS-irradiation. Klin P\u00e4diatr 2002; 214: 22\u201329.","journal-title":"Klin P\u00e4diatr"},{"key":"BF2403920_CR26","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s002770100304","volume":"80","author":"G Mann","year":"2001","unstructured":"Mann G, Reinhardt D, Ritter J, Hermann J, Schmitt K, Gadner H et al. Treatment with all-trans retinoid acid in acute promyelocytic leukemia reduces early deaths in children. Ann Hematol 2001; 80: 417\u2013422.","journal-title":"Ann Hematol"},{"key":"BF2403920_CR27","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1038\/sj.leu.2403814","volume":"19","author":"U Creutzig","year":"2005","unstructured":"Creutzig U, Reinhardt D, Diekamp S, Dworzak M, Stary J, Zimmermann M . AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity. Leukemia 2005; 19: 1355\u20131360.","journal-title":"Leukemia"},{"key":"BF2403920_CR28","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1002\/1097-0142(19871215)60:12<3071::AID-CNCR2820601235>3.0.CO;2-Y","volume":"60","author":"U Creutzig","year":"1987","unstructured":"Creutzig U, Ritter J, Budde M, Sutor A, Schellong G . Early deaths due to hemorrhage and leukostasis in childhood acute myelogenous leukemia: associations with hyperleukocytosis and acute monocytic leukemia. Cancer 1987; 60: 3071\u20133079.","journal-title":"Cancer"},{"key":"BF2403920_CR29","doi-asserted-by":"publisher","first-page":"4384","DOI":"10.1200\/JCO.2004.01.191","volume":"22","author":"U Creutzig","year":"2004","unstructured":"Creutzig U, Zimmermann M, Reinhardt D, Dworzak M, Stary J, Lehrnbecher T . Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98. J Clin Oncol 2004; 22: 4384\u20134393.","journal-title":"J Clin Oncol"},{"key":"BF2403920_CR30","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/sj.leu.2403188","volume":"18","author":"T Lehrnbecher","year":"2004","unstructured":"Lehrnbecher T, Varwig D, Kaiser J, Reinhardt D, Klingebiel T, Creutzig U . Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93. Leukemia 2004; 18: 72\u201377.","journal-title":"Leukemia"},{"key":"BF2403920_CR31","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1200\/JCO.2002.07.300","volume":"20","author":"Y Perel","year":"2002","unstructured":"Perel Y, Auvrignon A, Leblanc T, Vannier JP, Michel G, Nelken B, et al., for the Group LAME of the French Society of Pediatric Hematology and Immunology. Impact of addition of maintenance therapy to intensive induction and consolidation chemotherapy for childhood acute myeloblastic leukemia: results of a prospective randomized trial, LAME 89\/91. J Clin Oncol 2002; 20: 2774\u20132782.","journal-title":"J Clin Oncol"},{"key":"BF2403920_CR32","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1200\/JCO.1991.9.2.247","volume":"9","author":"CP Steuber","year":"1991","unstructured":"Steuber CP, Civin C, Krischer J, Culbert S, Ragab A, Ruymann FB et al. A comparison of induction and maintenance therapy for acute nonlymphocytic leukemia in childhood: Results of a Pediatric Oncology Group Study. J Clin Oncol 1991; 9: 247\u2013258.","journal-title":"J Clin Oncol"},{"key":"BF2403920_CR33","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1046\/j.1365-2141.2002.03697.x","volume":"118","author":"U Creutzig","year":"2002","unstructured":"Creutzig U, Reinhardt D . Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation? A European view. Br J Haematol 2002; 118: 365\u2013377.","journal-title":"Br J Haematol"},{"key":"BF2403920_CR34","first-page":"177","volume":"4","author":"Z Arlin","year":"1990","unstructured":"Arlin Z, Case-DC J, Moore J, Wiernik P, Feldman E, Saletan S et al. Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Lederle Cooperative Group. Leukemia 1990; 4: 177\u2013183.","journal-title":"Leukemia"},{"key":"BF2403920_CR35","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1182\/blood.V87.5.1710.1710","volume":"87","author":"JF Bishop","year":"1996","unstructured":"Bishop JF, Matthews JP, Young GA, Szer J, Gillett A, Joshua D et al. A randomized study of high-dose cytarabine in induction in acute myeloid leukemia. Blood 1996; 87: 1710\u20131717.","journal-title":"Blood"},{"key":"BF2403920_CR36","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1056\/NEJM199410063311402","volume":"331","author":"RJ Mayer","year":"1994","unstructured":"Mayer RJ, Davis RB, Schifffer CA, Berg DT, Powell BL, Schulman P et al. Intensive postremission chemotherapy in adults with acute myeloid leukemia. N Engl J Med 1994; 331: 896\u2013903.","journal-title":"N Engl J Med"},{"key":"BF2403920_CR37","first-page":"76","volume":"28","author":"T B\u00fcchner","year":"1991","unstructured":"B\u00fcchner T, Hiddemann W, L\u00f6ffler G, Gassmann W, Maschmeyer G, Heit W et al. Improved cure rate by very early intensification combined with prolonged maintenance chemotherapy in patients with acute myeloid leukemia: data from the AML Cooperative Group. Semin Hematol 1991; 28: 76\u201379.","journal-title":"Semin Hematol"},{"key":"BF2403920_CR38","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1046\/j.1365-2141.1998.00677.x","volume":"101","author":"RF Stevens","year":"1998","unstructured":"Stevens RF, Hann IM, Wheatley K, Gray RG, on behalf of the MRC Childhood Leukaemia Working Party. Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukaemia: results of the United Kingdom Medical Research Council's 10th AML trial. Br J Haematol 1998; 101: 130\u2013140.","journal-title":"Br J Haematol"},{"key":"BF2403920_CR39","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1046\/j.1365-2141.2003.04418.x","volume":"122","author":"SO Lie","year":"2003","unstructured":"Lie SO, Abrahamsson J, Clausen N, Forestier E, Hasle H, Hovi L et al. Treatment stratification based on initial in vivo response in acute myeloid leukaemia in children without Down's syndrome: results of NOPHO-AML trials. Br J Haematol 2003; 122: 217\u2013225.","journal-title":"Br J Haematol"},{"key":"BF2403920_CR40","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1200\/JCO.1993.11.3.538","volume":"11","author":"RJ Wells","year":"1993","unstructured":"Wells RJ, Woods WG, Lampkin BC, Nesbit ME, Lee JW, Buckley JD et al. Impact of high-dose cytarabine and asparaginase intensification on childhood acute myeloid leukemia: a report from the Children's Cancer Group. J Clin Oncol 1993; 11: 538\u2013545.","journal-title":"J Clin Oncol"},{"key":"BF2403920_CR41","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1200\/JCO.1993.11.8.1448","volume":"11","author":"WG Woods","year":"1993","unstructured":"Woods WG, Kobrinsky N, Buckley J, Neudorf S, Sanders J, Miller L et al. Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: a Children's Cancer Group pilot study. J Clin Oncol 1993; 11: 1448\u20131457.","journal-title":"J Clin Oncol"},{"key":"BF2403920_CR42","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1182\/blood.V95.1.72","volume":"95","author":"EH Estey","year":"2000","unstructured":"Estey EH, Shen Y, Thall PF . Effect of time to complete remission on subsequent survival and disease-free survival time in AML, RAEB-t, and RAEB. Blood 2000; 95: 72\u201377.","journal-title":"Blood"},{"key":"BF2403920_CR43","first-page":"1491","volume":"9","author":"N Dastugue","year":"1995","unstructured":"Dastugue N, Payen C, Lafage Pochitaloff M, Bernard P, Leroux D, Huguet Rigal F et al. Prognostic significance of karyotype in de novo adult acute myeloid leukemia. The BGMT group. Leukemia 1995; 9: 1491\u20131498.","journal-title":"Leukemia"},{"issue":"Suppl 3","key":"BF2403920_CR44","first-page":"S5","volume":"10","author":"T Haferlach","year":"1996","unstructured":"Haferlach T . More individual markers are necessary for patients with acute myeloid leukemia (AML). Leukemia 1996; 10 (Suppl 3): S5\u2013S9.","journal-title":"Leukemia"},{"key":"BF2403920_CR45","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/sj.leu.2402928","volume":"17","author":"DC Liang","year":"2003","unstructured":"Liang DC, Shih LY, Hung IJ, Yang CP, Chen SH, Jaing TH et al. FLT3-TKD mutation in childhood acute myeloid leukemia. Leukemia 2003; 17: 883\u2013886.","journal-title":"Leukemia"},{"key":"BF2403920_CR46","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1182\/blood-2002-12-3627","volume":"102","author":"CM Zwaan","year":"2003","unstructured":"Zwaan CM, Meshinchi S, Radich JP, Veerman AJ, Huismans DR, Munske L et al. FLT3 internal tandem duplication in 234 children with acute myeloid leukemia: prognostic significance and relation to cellular drug resistance. Blood 2003; 102: 2387\u20132394.","journal-title":"Blood"},{"key":"BF2403920_CR47","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1038\/sj.leu.2403480","volume":"18","author":"B George","year":"2004","unstructured":"George B, Mathews V, Poonkuzhali B, Shaji RV, Srivastava A, Chandy M . Treatment of children with newly diagnosed acute promyelocytic leukemia with arsenic trioxide: a single center experience. Leukemia 2004; 18: 1587\u20131590.","journal-title":"Leukemia"},{"key":"BF2403920_CR48","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/sj.leu.2401670","volume":"14","author":"U Creutzig","year":"2000","unstructured":"Creutzig U, K\u00f6rholz D, Niemeyer CM, Kabisch H, Graf N, Reiter A et al. 3 \u00d7 14\u2009mg idarubicin during induction. Results of a pilot study in children with AML. Leukemia 2000; 14: 340\u2013342.","journal-title":"Leukemia"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2403920.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403920","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403920.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T01:09:19Z","timestamp":1648775359000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2403920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,15]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["BF2403920"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2403920","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9,15]]},"assertion":[{"value":"14 December 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}